This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Tecomella undulata
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Desert tree whose bark is highly valued in Ayurveda for liver and spleen disorders, particularly hepatomegaly and splenomegaly.
Desert tree whose bark is highly valued in Ayurveda for liver and spleen disorders, particularly hepatomegaly and splenomegaly. Key active compounds include tecomin, lapachol, beta-sitosterol.
tecomin, along with lapachol and beta-sitosterol, are the primary bioactive compounds in Rohitaka. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth, stabilizes hepatocyte membranes and supports liver regeneration.
Hepatoprotective activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antitumor potential
Antimicrobial properties
Liver enlargement
Based on traditional use; clinical evidence limited
Spleen disorders
Based on traditional use; clinical evidence limited
Anemia treatment
Based on traditional use; clinical evidence limited
Skin diseases
Based on traditional use; clinical evidence limited
Found an error or have a correction for Rohitaka?
Report an Issue →